Publications - Leon Troper, M.D. Professorship

Home >
Publications

The results from the innovative cancer research supported by Dennis Troper and Susan Wojcicki have led to 120 papers being published to date acknowledging their generosity.

2024 ▼

Ando, Y., and Goggins, M. G. ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery. Ann Surg Oncol 31, 2961–2962 (2024).
Ando, Y.; Dbouk, M.; Blackford, A.L.; et al. Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. Ann Surg Oncol, 31, 2902–2912 (2024).
Ando, Y.; et al. Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer. Journal of Clinical Oncology, 42, 2196-2206(2024).
Ando, Y.; Dbouk, M.; Yoshida, T.; Abou Diwan, E.; Saba, H.; Dbouk, A.; ... and Goggins, M. G. (2024). Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers. JCO Precision Oncology, 8, e2400101.
Bowland, K.; et al. Islands of genomic stability in the face of genetically unstable metastatic cancer. bioRxiv (2024): 2024-01.
Braxton, A. M.; Kiemen, A. L.; Grahn, M. P.; Forjaz, A.; Parksong, J.; Mahesh Babu, J.; Lai, J.; Zheng, L.; Niknafs, N.; Jiang, L.; Cheng, H.; Song, Q.; Reichel, R.; Graham, S.; Damanakis, A. I.; Fischer, C. G.; Mou, S.; Metz, C.; Granger, J.; ... Wood, L. D. (2024). 3D genomic mapping reveals multifocality of human pancreatic precancers. Nature, 629(8012), 679-687.
Kiemen, A. L.; Dbouk, M.; Diwan, E. A.; Forjaz, A.; Dequiedt, L.; Baghdadi, A.; Madani, S. P.; Grahn, Mia, P.; Jones, C.; Vedula, S.; Wu, P-H.; Wirtz, D.; Kern, S.; Goggins, M. G.; Hruban, R. H.; Kamel, I. R.; Canto, M. I. Magnetic Resonance Imaging–Based Assessment of Pancreatic Fat Strongly Correlates With Histology-Based Assessment of Pancreas Composition. Pancreas 53(2):p e180-e186, February 2024.
Kiemen, A. L.; Forjaz, A.; Sousa, R.; Han, K. S.; Hruban, R. H.; Wood, L. D.; Wu, P.; and Wirtz, D. (2024). High-Resolution 3D Printing of Pancreatic Ductal Microanatomy Enabled by Serial Histology. Advanced Materials Technologies, 9(6), 2301837.
Kiemen, A.L.; Dequiedt, L.; Shen, Y.; Zhu, Y.; Matos-Romero, V.; Forjaz, A.; Campbell, K.; Dhana, W.; Cornish, T.; Braxton, A.; Wu, P-H.; Fishman, E. K.; Wood, L. D.; Wirtz, D.; Hruban, R. H. PanIN or IPMN? Redefining Lesion Size in 3 Dimensions. The American Journal of Surgical Pathology 48(7):p 839-845, July 2024.
Lih, T. M.; Liwei, C.; Parham, M.; Omenn, G. S.; Hruban, R. H.; Chan, D. W.; Bathe, O. F.; and Zhang, Z. Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. Molecular & Cellular Proteomics 23, no. 1 (2024).
Ni, Z.; Kundu, P.; McKean, D. F.; Wheeler, W.; Albanes, D.; Andreotti, G.; Antwi, S. O.; Arslan, A. A.; Bamlet, W.R.; Beane Freeman, L. E.; Berndt, S.I.; Bracci, P.M.; Brennan, P.; Buring, J. E.; Chanock, S. J.; Gallinger, S.; Gaziano, J. M.; Giles, G. G.; Giovannucci, E.L.; Goggins, M.G.; ... Klein, A.P. Genome-wide analysis to assess if heavy alcohol consumption modifies the association between SNPs and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2024 Jun 13. doi: 10.1158/1055-9965.EPI-24-0096. Epub ahead of print.
Teh, S. S. K.; Bowland, K.; Halper-Stromberg, E.; Kotwal, A.; Bennett, A.; Skaist, A.; Tang, J.; Cai, F.; Macoretta, A.; Liang, H.; Kamiyama, H.; Wheelan, S.; Lin, M. T.; Hruban, R.H.; Hung, C. F.; Goldstein, M.; Scharpf, R.B.; Roberts, N.J.; Eshleman, J.R. CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. NAR Cancer. 2024 Jun 19;6(2):zcae028.
Wang, Y.; Lih, T. M.; Lee, J. W.; Ohtsuka, T.; Hozaka, Y.; Mino-Kenudson, M.; Volkan Adsay, N.; Luchini, C.; Scarpa, A.; Maker, A. V.; Kim, G. E.; Paulino, J.; Chen, L.; Jiao, L.; Sun, Z.; Goodman, D.; Pflüger, M. J.; Roberts, N. J.; Matthaei, H.; Wood; Furukawa, T.; Zhang H.; and Hruban, R. H. Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression. bioRxiv (2024).
Yoshida, T.; Dbouk, M.; Hirose, K.; Abou Diwan, E.; Saba, H.; Dbouk, A.; and Goggins, M. G. (2024). Duodenal and pancreatic tissue microbiome profiles of PPI users and non-users. Pancreatology, 24(1), 188-195.

2023 ▼

Anaya, J.; Sidhom, J-W.; Mahmood, F.; and Baras, A. S. (2024). Multiple-instance learning of somatic mutations for the classification of tumour type and the prediction of microsatellite status. Nature Biomedical Engineering, 8(1), 57-67.
Anaya, J.; Sidhom, J-W.; Cummings, C. A.; and Baras, A.S. for AACR Project GENIE Consortium. Probabilistic Mixture Models Improve Calibration of Panel-derived Tumor Mutational Burden in the Context of both Tumor-normal and Tumor-only Sequencing. Cancer Research Communications 1 March 2023; 3 (3): 501–509.
Ben-Akiva, E.; Hickey, J. W.; Meyer, R. A.; Isser, A.; Shannon, S. R.; Livingston, N. K.; Rhodes, K. R.; Kosmides, A. K.; Warren, T. R.; Tzeng, S. Y.; Schneck, J. P.; and Green, J. J. (2023). Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy. Acta Biomaterialia, 160, 187-197.
Dbouk, M.; Abe, T.; Koi, C.; Ando, Y.; Saba, H.; Abou Diwan, E.; MacGregor-Das, A.; Blackford, A. L. ; Mocci, E.; Beierl, K.; Dbouk, A.; He, J.; Burkhart, R.; Lennon, A. M.; Sokoll, L.; Canto, M. I.; Eshleman, J. R. ; Goggins, M. G.; Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges. Clin Cancer Res 15 October 2023; 29 (20): 4178–4185.
Jeong, Y. J.; Knutsdottir, H.; Shojaeian, F.; Lerner, M. G.; Wissler, M. F.; Henriet, E.; ... and Wood, L. D. (2023). Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion. The Journal of Clinical Investigation, 133(8).
Kiemen, A. L., Choi, Y.G.; Braxton, A. M. ; Pérez, C. A.; Graham, S.; Grahn, M. P.; Nanda, N.; et al. Intraparenchymal Metastases as a Cause for Local Recurrence of Pancreatic Cancer. Histopathology, vol. 82, no. 3 (2023): 504-506.
Kimura, H.; Lahouel, K.; Tomasetti, C.; Roberts, N. J. Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity. bioRxiv 2023.12.28.573507.
Lennon, A. M. and Zaheer, A. Evaluation of Cystic Lesions Using EUS, MRI, and CT. The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, Fourth Edition (2023): 642-651.
Lindström, S.; Wang, L.; Feng, H.; Majumdar, A.; Huo, S.; Macdonald, J.; Harrison, T.; Turman, C.; Chen, H.; Mancuso, N.; Bammler, T.; Gallinger, S.; Gruber, S. B.; Gunter, M. J.; Le Marchand, L.; Moreno, V.; Offit, K.; De Vivo, I.; ... Kraft, P. (2023). Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. JNCI: Journal of the National Cancer Institute, 115(6), 712-732.
Mazer, B. L.; Lee, J. W.; Roberts, N. J.; Chu, L. C.; Lennon, A. M.; Klein, A. P.; ... Hruban, R. H. (2023). Screening for pancreatic cancer has the potential to save lives, but is it practical? Expert Review of Gastroenterology & Hepatology, 17(6), 555–574.
Paranal, R. M.; Jiang, Z.; Hutchings, D.; Kryklyva, V.; Gauthier, C.; Fujikura, K.; Nanda, N.; Huang, B.; Skaro, M.; Wolfgang, C. L.; He, J.; Klimstra, D. S.; Brand, R. E.; Singhi, A. D.; DeMarzo, A.; Zheng, L.; Goggins, M.; Brosens, L. A.; Hruban, R. H.; ... Roberts, N. J. (2023). Somatic loss of ATM is a late event in pancreatic tumorigenesis. The Journal of Pathology, 260(4), 455-464.
Pflüger, M. J.; Jamouss, K. T.; Afghani, E.; Lim, S. J.; Rodriguez Franco, S.; Mayo, H.; Spann, M.; Wang, H.; Singhi, A.; Lennon, A. M.; and Wood, L. D. (2023). Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis. Pancreatology, 23(7), 868-877.
Sohn, A.; Miller, D.; Ribeiro, E.; Shankar, N.; Ali, S.; Hruban, R. H.; and Baras, A. (2023). A deep learning model to triage and predict adenocarcinoma on pancreas cytology whole slide imaging. Scientific Reports, 13(1), 1-13.
Teh, S. S. K.; Bowland, K.; Bennett, A.; Halper-Stromberg, E.; Skaist, A.; Tang, J.; Cai, F.; Macoretta, A.; Liang, H.; Kamiyama, H.; Wheelan, S.; Lin, T.; Hruban, R. H.; Scharpf, R. B.; Roberts, N. J.; and Eshleman, J. R. CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. bioRxiv, 2023.
Teh, S. S. K.; Halper-Stromberg, E.; Morsberger, L.; Bennett, A.; Bowland, K.; Skaist, A.; Cai, F.; Liang, H.; Hruban, R. H.; Roberts, N. J.; Scharpf, R. B.; Zou, Y. S.; and Eshleman, J. R. Mechanism of delayed cell death following simultaneous CRISPR-Cas9 targeting in pancreatic cancers. bioRxiv, 2023.

2022 ▼

Anaya, J., and Baras, A. S. Read depth correction for somatic mutations. bioRxiv (2022).
Bell, A. T.; Mitchell, J. T.; Kiemen, A. L.; Fujikura, K.; Fedor, H.; Gambichler, B.; Deshpande, A.; et al. Spatial transcriptomics of FFPE pancreatic intraepithelial neoplasias reveals cellular and molecular alterations of progression to pancreatic ductal carcinoma. bioRxiv (2022).
Bell, A.T., Mitchell, J. T. ; Kiemen, A. L.; Fujikura, K.; Fedor, H.; Gambichler,B.; Deshpande, A.; et al. PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration. bioRxiv (2022): 2022-07.
Dbouk, M.; Katona, B. W.; Brand, R. E.; Chak, A.; Syngal, S.; Farrell, J. J.; Kastrinos, F., Stoffel, E. M.; Blackford, A. L.; Rustgi, A. K., Dudley, B.; Lee, L. S.; Chhoda, A.; Kwon, R.; Ginsberg, G. G., Klein, A. P.; Kamel, I.; Hruban, R. H.; He, J.; Shin, E.J.; Lennon, A.M.; Canto, M.I.; Goggins, M. G. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol. 2022 Oct 1;40(28):3257-3266.
Pflüger, M.J.; Griffin, J. F.; Hackeng, W. M.; Kawamoto, S.; Yu, J.; Chianchiano, P.; Shin, E.; Lionheart, G.; Tsai, H-L.; Wang, H.; Rezaee, N.; Burkhart, R. A.; Cameron, J. L.; Thompson, E. D.; Wolfgang, C. L.; He, J.; Brosens, L. A. A.; Wood, L. D. The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis. Annals of Surgery 275(6):p 1165-1174, June 2022.
Kawamoto, M.; Kohi, S.; Abe, T.; Dbouk, M.; Macgregor-Das, A.; Koi, C.; Song, B.; Borges, M.; Sugimine, R.; Laheru, D.; Hruban, R. H.; Roberts, N.; Klein, A. P.; and Goggins, M. G. (2022). Endoplasmic stress-inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case-control study and meta-analysis. International Journal of Cancer, 150(7), 1123-1133.
Kohi, S.; Macgregor-Das, A.; Dbouk, M.; Yoshida, T.; Chuidian, M.; Abe, T.; Borges, M.; Lennon, A. M.; Shin, E. J.; Canto, M. I.; and Goggins, M. G.(2022). Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer. Clinical Gastroenterology and Hepatology, 20(2), e196-e227.
Porter, N.; Laheru, D.; Lau, B.; He, J.; Zheng, L.; Narang, A.; Roberts, N. J.; Canto, M. I.; Lennon, A. M.; Goggins, M. G.; Hruban, R. H.; and Klein, A. P. (2022). Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds. JNCI: Journal of the National Cancer Institute, 114(12), 1681-1688.
Sung, B-Y.; Lin, Y-H.; Kong, Q.; Shah, P. D.; Glick Bieler, J.; Palmer, S.; Weinhold, K. J. ; Chang, H-R.; Huang, H.; Avery, R. K.; Schneck, J. P.; and Chiu, Y-L P. Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1.
The Journal of Clinical Investigation, 132.2 (2022).
Tanaka, H.; Tamura, K.; Abe, T.; Yoshida, T.; Macgregor-Das, A.; Dbouk, M.; Blackford, A. L.; Borges, M.; Lennon, A. M.; He, J.; Burkhart, R.; Canto, M. I.; and Goggins, M. G. (2022). Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. Clinical Gastroenterology and Hepatology, 20(10), 2267-2275.e2.

2021 ▼

Anaya, J. and Baras, A. S. The proposed promiscuity value of an HLA can vary significantly depending on the source data used. bioRxiv (2021): 2021-10.
Dbouk, M.; Brewer Gutierrez, O. I.; Lennon, A. M.; Chuidian, M.; Shin, E. J.; Kamel, I. R.; Fishman, E. K.; He, J.; Burkhart, R. A.; Wolfgang, C. L.; Hruban, R. H.; Goggins, M. G.; and Canto, M. I. (2021). Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements. Pancreatology, 21(3), 613-621.
Fujikura, K.; Alruwaii, Z. I.; Haffner, M. C.; Trujillo, M. A.; Roberts, N. J.; Hong, M., Macgregor-Das, A.; Goggins, M. G.; Roy, S.; Meeker, A. K.; Ding, D.; Wright, M.; He, J.; Hruban, R. H.; and Wood, L. D. (2021). Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis. The Journal of Pathology, 254(3), 279-288.
Hsu, F.; Roberts, N. J., Childs E; Porter, N.; Rabe, K.; Borgida, A.; Ukaegbu, C.; Goggins, M.G.; Hruban,R. H.; Zogopoulos, G.; Syngal, S.; Gallinger, S.; Petersen, G.M.; Klein, A. P. Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. JAMA Oncol. 2021;7(11):1664–1668.
Julián-Serrano, S., Yuan, F., Wheeler, W., Benyamin, B., Machiela, M. J., Arslan, A. A., Beane-Freeman, L. E., Bracci, P. M., Duell, E. J., Du, M., Gallinger, S., Giles, G. G., Goodman, P. J., Kooperberg, C., Marchand, L. L., Neale, R. E., Shu, X., Van Den Eeden, S. K., Visvanathan, K., ... Goggins, M.G., et al. (2021). Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: A pathway analysis of genome-wide association studies. The American Journal of Clinical Nutrition, 114(4), 1408-1417.
Mocci, E.; Kundu, P.; Wheeler, W.; Arslan, A. A.; Beane-Freeman, L. E.; Bracci, P. M.; ... Goggins, M. G.; et al. (2021). Smoking modifies pancreatic cancer risk loci on 2q21. 3. Cancer Tesearch, 81(11), 3134-3143.
Rhodes, K. R.; Isser, A.; Hickey, J. W.; Ben-Akiva, E.; Meyer, R. A.; Kosmides, A. K.; Livingston, N. K. ; Tzeng, S. Y.; Schneck, J. P.; and Green, J. J. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma. ACS Applied Materials & Interfaces 2021 13 (7), 7913-7923.
Roberts, N. J.; Grant, R.C.; Gallinger, S.; Klein, A. P.; the Familial Pancreatic Cancer Genome Sequencing Project. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants. Genes Chromosomes Cancer. 2021; 60: 559–564.
Sidhom, J.; Siddarthan, I. J.; Lai, B.; Luo, A.; Hambley, B. C.; Bynum, J.; Duffield, A. S.; Streiff, M. B.; Moliterno, A. R.; Imus, P.; Gocke, C. B.; Gondek, L. P.; DeZern, A. E.; Baras, A. S.; Kickler, T.; Levis, M. J.; and Shenderov, E. (2021). Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features. Npj Precision Oncology, 5(1), 1-8.
Sidhom, J.; Larman, H. B.; Pardoll, D. M.; and Baras, A. S. (2021). DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires. Nature Communications, 12(1), 1-12.
Sidhom, J., and Baras, A. S. (2021). Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires. Scientific Reports, 11(1), 1-8.
Singhi, A. D., and Wood, L. D. (2021). Early detection of pancreatic cancer using DNA-based molecular approaches. Nature Reviews Gastroenterology & Hepatology, 18(7), 457-468.

2020 ▼

Abe, T.; Koi, C.; Kohi, S.; Song, K.; Tamura, K.; Macgregor-Das, A.; Kitaoka, N.; Chuidian, M.; Ford, M.; Dbouk, M.; Borges, M.; He, J.; Burkhart, R.; Wolfgang, C. L.; Klein, A. P.; Eshleman, J. R.; Hruban, R. H.; Canto, M. I.; and Goggins, M. (2020). Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer. Clinical Gastroenterology and Hepatology, 18(5), 1161-1169.e5.
Bessell, C. A.; Isser, A.; Havel, J. J.; Lee, S.; Bell, D. R.; Hickey, J. W.; Chaisawangwong, W.; Bieler, J. G.; Srivastava, R.; Kuo, F.; Purohit, T.; Zhou, R.; Chan, T. A.; and Schneck, J. P. (2020). Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI Insight, 5(8).
Canto, M.I.; Kerdsirichairat ,T.; Yeo, C. J.; Hruban, R.H.; Shin, E.J.; Almario, J.A.; Blackford, A.; Ford, M.; Klein, A. P.; Javed, A. A.; Lennon, A. M. Surgical outcomes after pancreatic resection of screening-detected lesions in individuals at high risk for developing pancreatic cancer. Journal of Gastrointestinal Surgery. 2020 May;24:1101-10.
Felsenstein, M.; Trujillo, M. A.; Huang, B.; Nanda, N.; Jiang, Z.; Jeong, Y.J.; Pflüger, M.; Goggins, M. G., Hruban, R. H.; Thompson, E. D.; Heaphy, C. M.; Roberts, N. J.; Wood, L. D. Generation and characterization of a cell line from an intraductal tubulopapillary neoplasm of the pancreas. Lab Invest. 2020 Jul;100(7):1003-1013.
Fujikura, K.; Hutchings, D.; Braxton, A. M.; Zhu, Q.; Laheru, D. A.; Hruban, R. H.; Thompson, E. D.; and Wood, L. D. (2020). Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy. Modern Pathology, 33(10), 2026-2034.
Fujikura, K.; Hosoda, W.; Felsenstein, M.; Song, Q.; Reiter, J. G.; Zheng, L.; Guthrie, V. B.; Rincon, N.; Dal Molin, M.; Dudley, J.; Cohen, J. D. ... Wood LD. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions. Gut. 2021 May 1;70(5):928-39.
Hickey, J. W.; Isser, A.; Salathe, S. F.; Gee, K. M.; Hsiao, M.-H., Shaikh, W.; Uzoukwu, N. C.; Bieler, J. G.; Mao, H-Q.; and Schneck, J. P. Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cells. Nano Letters 2020 20 (9), 6289-6298.
Hong, S.; Jung, D.; Kiemen, A.; Gaida, M. M.; Yoshizawa, T.; Braxton, A. M.; Noë, M.; Lionheart, G.; Oshima, K.; Thompson, E. D.; Burkhart, R.; Wu, P.; Wirtz, D.; Hruban, R. H.; and Wood, L. D. (2020). Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion. Modern Pathology, 33(4), 639-647.
Huang, W.; Navarro-Serer, B.; Jeong, Y. J.; Chianchiano, P.; Xia, L.; Luchini, C.; Veronese, N.; Dowiak, C.; Ng, T.; Trujillo, M. A.; Huang, B.; Pflüger, M. J.; Macgregor-Das, A. M.; Lionheart, G.; . . . He, Jin; Wolfgang, C. L.; Goggins, M. G.; Thompson, E. D.; Roberts, N. J.; Ewald, A. J.; Wood, L. D. Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. Cancer Res 1 July 2020; 80 (13): 2804–2817.
Ichikawa, J.; Yoshida, T.; Isser, A.; Laino, A. S.; Vassallo, M.; Woods, D.; Kim, S.; Oelke, M.; Jones, K.; Schneck, J. P.; Weber, J. S. Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells. Clin Cancer Res 1 July 2020; 26 (13): 3384–3396.
Lennon, A. M.; Buchanan, A. H.; Kinde, I.; Warren, A.; Honushefsky, A.; Cohain, A. T.; Ledbetter, D. H.; Sanfilippo, F.; Sheridan, K.; Rosica, D.; Adonizio, C. S.; Hwang, H. J.; Lahouel, K.; Cohen, J. D.; Douville, C.; Patel, A. A.; Hagmann, L. N.; Rolston, D. D.; Malani, N.; ... Papadopoulos, N. (2020). Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science.
Macgregor-Das, A.; Yu, J.; Tamura, K.; Abe, T.; Suenaga, M.; Shindo, K.; Borges, M.; Koi, C.; Kohi, S.; Sadakari, Y.; Dal Molin, M.; Almario, J. A.; Ford, M.; Chuidian, M.; Burkhart, R.; He, J.; Hruban, R. H.; Eshleman, J. R.; Klein, A. P.; ... Goggins, M. G. (2020). Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. The Journal of Molecular Diagnostics, 22(6), 748-756.
Noë, M.; Niknafs, N.; Fischer, C. G.; Hackeng, W. M.; Beleva Guthrie, V.; Hosoda, W.; Debeljak, M.; Papp, E.; Adleff, V.; White, J. R.; Luchini, C.; Pea, A.; Scarpa, A.; Butturini, G.; Zamboni, G.; Castelli, P.; Hong, S.; Yachida, S.; Hiraoka, N.; . . . Wood, L. D. (2020). Genomic characterization of malignant progression in neoplastic pancreatic cysts. Nature Communications, 11(1), 1-12.
Oni, T. E.; Bautista, C.; Merrill, J. R.; Goos, J. A.C.M.; Rivera, K. D.; Miyabayashi, K.; Biffi, G.; Garcia, L.; Plenker, D.; Patel, H.; Elyada, E.; Samaritano, M.; Yu, K. H.; Pappin, D. J.; Goggins, M. G.; Hruban, R.H.; Lewis, J. S.; Lyons, S. K.; Yeh, J. T.; Tuveson, D. A. Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models. bioRxiv 2020.09.10.292193.
Sagara, T.; Debeljak, M.; Wright, C. M.; Anders, N. M.; Liang, H.; Rudek, M. A.; ... Matsushita, Y. (2020). Successful gene therapy requires targeting the vast majority of cancer cells. Cancer Biology & Therapy, 21(10), 946–953.
Tang, H.; Jiang, L.; Stolzenberg-Solomon, R. Z.; ... Goggins, M. G.; ... Klein, A. P.; Li, D.; Kraft, P.; Wei, P. Genome-Wide Gene–Diabetes and Gene–Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Cancer Epidemiol Biomarkers Prev 1 September 2020; 29 (9): 1784–1791.
Thompson, E. D.; Wood, L. D. Pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features. Arch Pathol Lab Med. 2020 Jul 1;144(7):808-815.
Yuan, F.; Hung, R. J.; Walsh, N.; Zhang, H.; Platz, E. A.; Wheeler, W.; ...Goggins, M. G.; ... and Stolzenberg-Solomon, R. (2020). Genome-wide association study data reveal genetic susceptibility to chronic inflammatory intestinal diseases and pancreatic ductal adenocarcinoma risk. Cancer Research, 80(18), 4004-4013.

2019 ▼

Abe, T.; Blackford, A. L.; Tamura, K.; Ford, M.; McCormick, P.; Chuidian, M.; Almario, J. A.; Borges, M.; Lennon, A. M.; Shin, E. J.; Klein, A. P.; Hruban, R. H.; Canto, M. I.; and Goggins, M. G. (2019). Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. Journal of Clinical Oncology, 37(13), 1070-1080.
Fischer, C.G.; Beleva, G. V.; Braxton, A.M.; Zheng, L.; Wang, P.; Song, Q.; Griffin, J.F.; Chianchiano, P.E.; Hosoda, W.; Niknafs, N.; Springer, S.; Dal Molin, M.; Masica, D.; Scharpf, R.B.; Thompson, E.D.; He, J.; Wolfgang, C.L.; Hruban, R.H.; Roberts, N.J.; Lennon, A.M.; Jiao, Y.; Karchin, R.; Wood, L.D. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. Gastroenterology. 2019 Oct;157(4):1123-1137.e22. doi: 10.1053/j.gastro.2019.06.001. Epub 2019 Jun 5.
Hutchings, D.; Jiang, Z.; Skaro, M.l; Weiss, M. J.; Wolfgang, C. L.; Makary, M. A.; He, J.; Cameron, J. L.; Zheng, L.; Klimstra, D. S.; Brand, R. E.; Singhi, A. D.; Goggins, M.; Klein, A. P.; Roberts, N. J.; and Hruban, R. H. (2019). Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants. Modern Pathology, 32(12), 1806-1813.
Matsushita, Y.; Smith, B.; Delannoy, M.; Trujillo, M. A.; Chianchiano, P.; McMillan, R.; Kamiyama, H.; Liang, H.; Thompson, E. D.; Hruban, R. H.; Matsui, W.; Wood, L. D.; Roberts, N. J.; Eshleman, J. R. Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture. Pancreas 48(9):p 1225-1231, October 2019.
Poruk, K. E.; Griffin, J.; Makary, M. A.; He, J.; Cameron, J. L.; Weiss, M. J.; Wood, L. D.; Goggins, M. G.; and Wolfgang, C. L. (2019). Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms. Journal of Gastrointestinal Surgery, 23(3), 477-483.
Skaro, M.; Nanda, N.; Gauthier, C.; Felsenstein, M.; Jiang, Z.; Qiu, M.; Shindo, K.; Yu, J.; Hutchings, D.; Javed, A. A.; Beckman, R.; He, J.; Wolfgang, C. L.; Thompson, E.; Hruban, R. H.; Klein, A. P.; Goggins, M. G.; Wood, L. D.; and Roberts, N. J. (2019). Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. Gastroenterology, 156(6), 1905-1913.
Springer, S., Masica, D. L., Dal Molin, M., Douville, C., Thoburn, C. J., Afsari, B., ... & Lennon, A. M. (2019). A multimodality test to guide the management of patients with a pancreatic cyst. Science Translational Medicine, 11(501), eaav4772.

2018 ▼

Canto, M. I.; Almario, J. A.; Schulick, R. D.; Yeo, C. J.; Klein, A.; Blackford, A.; Shin, E. J.; Sanyal, A,; Yenokyan, G.; Lennon, A. M.; Kamel, I. R.; Fishman, E. K.; Wolfgang, C. L.; Weiss, M.; Hruban, R.H.; Goggins, M. G. Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology. 2018 Sep 1;155(3):740-51.
Cohen, J.D.; Li, L.; Wang, Y.; Thoburn, C.; Afsari, B.; Danilova, L.; Douville, C.; Javed, A. A.; Wong, F.; Mattox, A.; Hruban, R.H. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018 Feb 23;359(6378):926-30.
Goggins, M. G. Screening of Patients with Hereditary Pancreatic Cancer. The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery (2018): 745-754.
Grant, R. C.; Denroche, R. E.; Borgida, A.; Virtanen, C.; Cook, N.; Smith, A. L.; Connor,
A. A.; Wilson, J. M.; Peterson, G.; Roberts, N. J.; Klein, A. P.; Grimmond, S. M.; Biankin, A.; Cleary, S.; Moore, M.; Lemire, M.; Zogopoulos, G.; Stein, L.; and Gallinger, S. (2018). Exome-Wide Association Study of Pancreatic Cancer Risk. Gastroenterology, 154(3), 719-722.e3.
Hata, T.; Dal Molin, M.; McGregor-Das, A.; Song, T. J.; Wolfgang, C. L.; Eshleman, J. R.; Hruban, R. H.; and Goggins, M. G. (2018). Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. The Journal of Molecular Diagnostics, 20(1), 46-55.
Hata, T.; Suenaga, M.; Marchionni, L.; Macgregor-Das, A.; Yu, J.; Shindo, K.; Tamura, K.; Hruban, R. H.; and Goggins, M. G. (2018). Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. The American Journal of Pathology, 188(7), 1723-1733.
Klein, A. P.; Wolpin, B. M.; Risch, H. A.; . . . Amundadottir, L. T. (2018). Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications, 9(1), 1-11.
Kosmides, A. K.; Necochea, K.; Hickey, J.W.; and Schneck, J. P. Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation. Nano Letters 2018 18 (3), 1916-1924.
Sidhom, J-W.; Bessell, C. A.; Havel, J. J.; Kosmides, A.; Chan, T. A.; Schneck, J. P. ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis. Cancer Immunol Res 1 February 2018; 6 (2): 151–162.
Suenaga, M.; Yu, J.; Shindo, K.; Tamura, K.; Almario, J. A.; Zaykoski, C.; Witmer, P. D.; Fesharakizadeh, S.; Borges, M.; Lennon, A. M.; Shin, E. J.; Canto, M. I.; Goggins, M. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance. Clin Cancer Res 15 June 2018; 24 (12): 2963–2974.
Suenaga, M.; Dudley, B.; Karloski, E.; Borges, M.; Canto, M. I.; Brand, R. E.; Goggins, M. G. The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations. Pancreas 47(1):p 35-39, January 2018.
Tamura, K.; Yu, J.; Hata, T.; Suenaga, M.; Shindo, K.; Abe, T.; Borges, M.; Wolfgang, C. L.; Weiss, M. J.; He, J.; Canto, M. I.; Petersen, G. M.; Gallinger, S.; Syngal, S.; Brand, R. E.; Rustgi, A.; Olson, S. H.; Stoffel, E.; Cote, M. L.; . . . Goggins, M. G. (2018). Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proceedings of the National Academy of Sciences, 115(18), 4767-4772.

2017 ▼

Ayars, M.; Eshleman, J. R.; and Goggins, M. G. (2017). Susceptibility of ATM-deficient pancreatic cancer cells to radiation. Cell Cycle, 16(10), 991–998.
Cohen, J. D.; Javed, A. A.; Thoburn, C.; Wong, F.; Tie, J.; Gibbs, P.; Schmidt, C. M.; Yip-Schneider, M. T.; Allen, P. J.; Schattner, M.; Brand, R. E.; Singhi, A. D.; Petersen, G. M.; Hong, S.; Kim, S. C.; Falconi, M.; Doglioni, C.; Weiss, M. J.; Ahuja, N.; . . . Lennon, A. M. (2017). Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proceedings of the National Academy of Sciences, 114(38), 10202-10207.
Dal Molin, M.; Blackford, A. L.; Siddiqui, A.; et al. Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 24, 2379–2386 (2017).
Goggins, M.G. Editorial: Circulating Biomarkers to Identify Patients With Resectable Pancreatic Cancer, JNCI: Journal of the National Cancer Institute, Volume 109, Issue 8, August 2017, djx004.
Hata, T.; Dal Molin, M.; Hong, S-M.; Tamura, K.; Suenaga, M.; Yu, J.; Sedogawa, H.; Weiss, M. J.; Wolfgang, C. L.; Lennon, A. M.; Hruban, R. H.; Goggins, M. G. Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers. Clin Cancer Res 15 July 2017; 23 (14): 3935–3944.
Kosmides, A.; Meyer, R.; Hickey, J.; Aje, K.; Cheung, K.; Green, J.; and Schneck, J. P. (2017). Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma. Biomaterials, 118, 16-26.
Lennon, A. M.; Canto, M. I. Pancreatic Cysts - Part 2: Should We Be Less Cyst Centric? Pancreas 46(6):p 745-750, July 2017.
Masica, D. L.; Dal Molin, M.; Wolfgang, C. L.; Tomita, T.; Ostovaneh, M. R.; Blackford, A.; Moran, R. A.; Law, J. K.; Barkley, T.; Goggins, M.; Canto, M. I.; Pittman, M.; Eshleman, J. R.; Ali, S. Z.; Fishman, E. K.; Kamel, I. R.; Raman, S. P.; Zaheer, A.; Ahuja, N.; . . . Lennon, A. M. (2017). A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts. Journal of the American Medical Informatics Association, 24(1), 145-152.
Pea, A.; Yu, J.; Rezaee, N.; Luchini, C.; He, J.; Dal Molin, M.; Griffin, J. F.; Fedor, H; Fesharakizadeh, S.; Salvia, R.; Weiss, M. J.; Bassi, C.; Cameron, J. L.; Zheng, L.; Scarpa, A.; Hruban, R. H.; Lennon, A. M.; Goggins, M. G.; Wolfgang, C. L.; Wood, L. D. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Annals of Surgery 266(1):p 133-141, July 2017.
Shindo, K.; Yu, J.; Suenaga, M.; Fesharakizadeh, S.; Cho, C.; Macgregor-Das, A.; Siddiqui, A.; Witmer, P. D.; Tamura, K.; Song, T. J.; Navarro Almario, J. A.; Brant, A.; Borges, M.; Ford, M.; Barkley, T.; He, J.; Weiss, M. J.; Wolfgang, C. L.; Roberts, N. J.; Hruban, R. H. ; Klein, A. P.; Goggins, M.G. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. Journal of Clinical Oncology 2017 35:30, 3382-3390.
Shindo, K.; Yu, J.; Suenaga, M.; Fesharakizadeh, S.; Tamura, K.; Navarro Almario, J. A.; Brant, A.; Borges, M.; Siddiqui, A.; Datta, L.; Wolfgang, C. L.; Hruban, R. H.; Klein, A. P.; and Goggins, M. G. (2017). Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer. Oncotarget, 8(31), 50824-50831.
Suenaga, M.; Sadakari, Y.; Almario, J. A.; Borges, M.; Lennon, A.; Shin, E.; Canto, M. I.; and Goggins, M. G. (2017). Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video). Gastrointestinal Endoscopy, 86(6), 1152-1156.e2. https://doi.org/10.1016/j.gie.2017.02.026
Yu, J.; Sadakari, Y.; Shindo, K.; Suenaga, M.; Brant, A.; Almario, J. A. N.; Borges, M.; Barkley, T.; Fesharakizadeh, S.; Ford, M.; Hruban, R.H.; and Goggins, M. G. (2017). Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Gut, 66(9), 1677-1687.

2016 ▼

Childs, E. J.; Chaffee, K. G.; Gallinger, S.; Syngal, S.; Schwartz, A. G.; Cote, M. L.; Bondy, M. L.; Hruban, R. H. ; Chanock, S. J.; Hoover, R. N.; Fuchs, C. S.; Rider, D. N.; Amundadottir, L. T.; Stolzenberg-Solomon, R.; Wolpin, B. M.; Risch, H. A.; Goggins, M. G.; Petersen, G. M.; Klein A. P. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study. Cancer Epidemiol Biomarkers Prev 1 July 2016; 25 (7): 1185–1191.
Dal Molin, M.; Kim, H.; Blackford, A.; Sharma, R.; Goggins, M. G. Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues. Pancreas 45(4):p 613-619, April 2016.
Hata, T.; Dal Molin, M.; Suenaga, M.; Yu, J.; Pittman, M.; Weiss, M.; Canto, M. I.; Wolfgang, C. L.; Lennon, A. M.; Hruban, R. H.; Goggins, M. G. Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas. Clin Cancer Res 15 October 2016; 22 (20): 5141–5151.
Ngamruengphong, S., and Lennon, A. M. (2016). Analysis of Pancreatic Cyst Fluid. Surgical Pathology Clinics, 9(4), 677-684.
Omura, N.; Mizuma, M.; MacGregor, A.; Hong, S. M.; Ayars, M.; Almario, J. A.; Borges, M.; Kanda, M.; Li, A.; Vincent, A.; Maitra, A.; Goggins, M. G. Overexpression of ankyrin1 promotes pancreatic cancer cell growth. Oncotarget. 2016 Jun 7;7(23):34977-87.

2015 ▼

Eshleman, J. R.; Norris, A. L.; Sadakari, Y.; Debeljak, M.; Borges, M.; Harrington, C.; Lin, E.; Brant, A.; Barkley, T.; Almario, J. A.; Topazian, M.; Farrell, J.; Syngal, S.; Lee, J. H.; Yu, J.; Hruban, R. H.; Kanda, M.; Canto, M. I.; and Goggins, M. G. (2015). KRAS and Guanine Nucleotide-Binding Protein Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound. Clinical Gastroenterology and Hepatology, 13(5), 963-969.e4.
Jiao, Y.; Lumpkins, K.; Terhune, J.; Hruban, R. H.; Klein, A.; Kinzler, K. W.; Papadopoulos, N.; Vogelstein, B.; Strauch, E. Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation. Pancreatology, Volume 15, Issue 2,2015, Pages 194-196,ISSN 1424-3903.
Perica, K.; Glick Bieler, J.; Schütz, C.; Varela, J. C.; Douglass, J.; Skora, A.; Chiu, Y. L.; Oelke, M.; Kinzler, K.; Zhou, S.; Vogelstein, B.; and Schneck, J. P. (2015) Enrichment and expansion with nanoscale artificial antigen presenting cells for adoptive immunotherapy. ACS nano, 9(7), 6861-6871.
Singhi, A. D.; Ishida, H.; Ali, S. Z.; Goggins, M.; Canto, M.; Wolfgang, C. L.; Meriden, Z.; Roberts, N.; Klein, A. P.; and Hruban, R. H. (2015). A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology, 15(4), 387-391.
Springer, S.; Wang, Y.; Dal Molin, M.; Masica, D. L.; Jiao, Y.; Kinde, I.; Blackford, A.; Raman, S. P.; Wolfgang, C. L.; Tomita, T.; Niknafs, N.; Douville, C.; Ptak, J.; Dobbyn, L.; Allen, P. J.; Klimstra, D. S.; Schattner, M. A.; Schmidt, C. M.; Yip-Schneider, M.; . . . Lennon, A. M. (2015). A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. Gastroenterology, 149(6), 1501-1510.
Yu, J.; Blackford, A. L.; Dal Molin, M.; Wolfgang, C. L.; Goggins, M. G.; Yu, J.; et al. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut 64.11 (2015): 1783-1789.

2014 ▼

Amato, E.; Mafficini, A.; Yu, J.; Malleo, G.; Rusev, B.; Fassan, M.; Antonello, D.; Sadakari, Y.; Castelli, P.; Zamboni, G.; Maitra, A.; Salvia, R.; Hruban, R. H.; Bassi, C.; Capelli, P.; Lawlor, R. T.; Goggins, M. G.; and Scarpa, A. (2014). Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. The Journal of Pathology, 233(3), 217-227.
Kim, H.; Saka, B.; Knight, S.; Borges, M.; Childs, E.; Klein, A.; Wolfgang, C. L.; Herman, J.; Adsay, V. N.; Hruban, R. H.; Goggins, M. Having Pancreatic Cancer with Tumoral Loss of ATM and Normal TP53 Protein Expression Is Associated with a Poorer Prognosis. Clin Cancer Res 1 April 2014; 20 (7): 1865–1872.
Lennon, A. M.; Wolfgang, C. L.; Canto, M. I.; Klein, A. P.; Herman, J. M.; Goggins, M. G.; Fishman, E. K.; Kamel, I.; Weiss, M. J.; Diaz, L. A.; Papadopoulos, N.; Kinzler, K. W.; Vogelstein, B.; Hruban. R. H. The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? Cancer Res 1 July 2014; 74 (13): 3381–3389.
Sadakari, Y.; Kanda, M.; Maitani, K.; Borges, M.; Canto, M. I.; Goggins, M. G. Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen. Clinical and Translational Gastroenterology 5(11):p e62, November 2014.

2013 ▼

Kanda, M.; Sadakari, Y.; Borges, M.; Topazian, M.; Farrell, J.; Syngal, S.; Lee, J.; Kamel, I.; Lennon, A. M.; Knight, S.; Fujiwara, S.; Hruban, R. H.; Canto, M. I.; Goggins, M. G. Mutant TP53 in Duodenal Samples of Pancreatic Juice From Patients With Pancreatic Cancer or High-Grade Dysplasia, Clinical Gastroenterology and Hepatology, Volume 11, Issue 6, 2013, Pages
Li, A., Yu, J., Kim, H., Wolfgang, C. L., Canto, M. I., Hruban, R. H., & Goggins, M. (2013). Serum miR-1290 as a marker of pancreatic cancer response. Clinical Cancer Research, 19(18), 5252-5253.
Li, A.; Yu, J.; Kim, H.; Wolfgang, C. L.; Canto, M. I.; Hruban, R. H.; Goggins M. G. MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls. Clin Cancer Res 1 July 2013; 19 (13): 3600–3610.